Monitoring of HMG-stimulated follicular development by real-time ultrasound.
Monitoring of human follicular development by real-time ultrasound during HMG-HCG treatment is presented. With the aid of ultrasound monitoring, the ovulation rate is raised to 94.3% (formerly 80% without ultrasound). Serious side effects such as ascites and/or hydrothorax did not occur in this study (1.2% without ultrasound controls). The pregnancy rate was 21/47 (44%) of all hormonally treated patients. By means of real-time sector scan examination, the growing follicle could be detected in 103/106 (97.3%) of HMG-HCG treated cycles. Thus real-time ultrasound examinations provide results comparable to those achieved mostly by time-consuming compound scan in demonstration of the growing follicle.
D000858:Anovulation / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D004958:Estradiol / Q000032:analysis; D005260:Female; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use*; D008991:Monitoring, Physiologic / Q000379:methods*; D010053:Ovary / Q000187:drug effects / Q000502:physiology; D010062:Ovulation Induction; D014463:Ultrasonography
D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins